Health Condition 1: N00-N99- Diseases of the genitourinary system
Conditions
Interventions
Intervention1: Intrathecal morphine: Intrathecal morphine injection will be given to the case groups at 200micrograms or 0.3 micrograms per KG whichever is lower and compared with the control group
Co
Sponsors
BHAVYA PURI
Eligibility
Inclusion criteria
Inclusion criteria: Female patients aged more than18 years up to 70 years ASA physical status I to ASAIII Patient scheduled for elective laparoscopic hysterectomy Ability to understand and complete the QoR-15 questionnaire
Exclusion criteria
Exclusion criteria: Declined consent to participate Contraindication to intrathecal morphine Morbid obesity BMI more than 35 kg per m2 History of chronic opioid use or opioid dependence Severe hepatic, renal, or respiratory disease Contraindications to neuraxial anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the impact of implementing ITM on QOR of patients undergoing laparoscopic-assisted hysterectomy between 18 to 70 years of age.Timepoint: pod 1 | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of recovery score on POD 2 and 3 Timepoint: pod 2 pod 3;To compare post-operative pain scores between both groups. Timepoint: ;To compare post-operative analgesia/ IV-opioid requirement in both groups.Timepoint: ;To assess adverse effects related to the administration of intrathecal morphineTimepoint: ;To assess the difference in length of hospital stay and overall patient satisfactionTimepoint: | — |
Countries
India
Contacts
Public ContactDR RASHI SARNA
PGIMER CHANDIGARH
Outcome results
None listed